1Y Annualised Return
▼-21.81%
3Y Annualised Return
▲41.00%
5Y Annualised Return
▲28.88%
10Y Annualised Return
▼-3.20%
Beryl Drugs Stock Performance
|
|
|
Beryl Drugs Company background
Founded in: 1993
Managing director: Sanjay Sethi
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplicillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Beryl Drugs Financial Highlights
For the full year FY2018–2019, revenue
reached ₹15.99 crore and profit touched at
₹0.99 crore.
As of 6 Sep, 2025, Beryl Drugs share price is ₹24.1. The stock opened at ₹26 and had closed at ₹24.4 the previous day. During today’s trading session, Beryl Drugs share price moved between ₹24.01 and ₹25.99, with an average price for the day of ₹25.00. Over the last 52 weeks, the stock has recorded a low of ₹17.35 and a high of ₹46.00. In terms of performance, Beryl Drugs share price has declined by 2% over the past six months and has declined by 21.81% over the last year.
Beryl Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹58,37,307 (-10.20%)
Daily SIP of ₹25,000 would have become ₹58,37,307 in 1 year with a gain of ₹-6,62,692 (-10.20%)
Beryl Drugs Fundamental
Market Cap (in crs)
12.20
Face Value
10
Turnover (in lacs)
0.63
Key Metrics
Qtr Change %
47.70% Fall from 52W High
19.4
Dividend yield 1yr %
0
Beryl Drugs Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Beryl Drugs Quarterly Revenue
| Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 |
|---|---|---|---|---|
4.73 Cr | 3.63 Cr | 3.24 Cr | 4.88 Cr | 2.51 Cr |
Beryl Drugs Yearly Revenue
| Mar 2018 | Mar 2017 |
|---|---|
15.99 Cr | 11.53 Cr |
Beryl Drugs Quarterly Net Profit/Loss
| Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 |
|---|---|---|---|---|
0.88 Cr | 0.1 Cr | 0.09 Cr | 0.03 Cr | -0.02 Cr |
Beryl Drugs Yearly Net Profit/Loss
| Mar 2018 | Mar 2017 |
|---|---|
0.99 Cr | -0.41 Cr |
Beryl Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
24.06
Current Price
5Day EMA
24.50
10Day EMA
24.20
12Day EMA
24.00
20Day EMA
23.30
26Day EMA
22.80
50Day EMA
22.00
100Day EMA
22.50
200Day EMA
24.80
5Day SMA
24.80
10Day SMA
24.80
20Day SMA
22.50
30Day SMA
21.90
50Day SMA
21.80
100Day SMA
20.90
150Day SMA
23.00
200Day SMA
26.20
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2071 Rs | 2605 Rs |
Week Rs | 3379 Rs | 4352 Rs |
Month Rs | 3826 Rs | 4615 Rs |
Resistance & Support
24.69
Pivot
Resistance
First Resistance
25.36
Second Resistance
26.67
Third Resistance
27.34
Support
First Support
23.38
Second support
22.71
Third Support
21.40
Relative Strength Index
55.28
Money Flow Index
55.99
MACD
1.16
MACD Signal
1.02
Average True Range
1.88
Average Directional Index
25.52
Rate of Change (21)
17.25
Rate of Change (125)
-1.60
Beryl Drugs Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23.42 | 12.79 | 19.01 | 45.3 | 22.31 | 9.95% | 19.98% | -26.19% | 26.59% | 94.03% | 0.00% | 15.82 | 38.54 | 0.37 | |
10.75 | 10.86 | 9.61 | 18.9 | 10.20 | 0.84% | -0.46% | -4.95% | -38.11% | -76.61% | 0.00% | 0.00 | 40.57 | 1.28 | |
25.08 | 13.14 | 6.27 | 36.96 | 26.00 | -21.35% | -3.65% | 23.49% | 500.00% | 500.00% | 0.00% | 0.00 | 40.57 | 2.99 | |
24.52 | 10.99 | 19.99 | 39 | 24.85 | -1.01% | 1.62% | 1.41% | -9.19% | 146.68% | 0.00% | 111.45 | 40.57 | 3.50 | |
Satiate Agri Ltd. | - | 40.94 | - | - | - | - | - | - | - | - | - | - | - | - |
35.76 | 13.38 | 31.5 | 55.02 | 36.21 | 0.76% | -4.59% | -13.83% | 6.75% | 5.64% | 0.00% | 0.00 | 40.57 | -4.96 |
Beryl Drugs Latest News
Beryl Drugs Share Price FAQs
How to buy Beryl Drugs shares?
You can easily buy Beryl Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Beryl Drugs ?
The 52-week high and low of Beryl Drugs share price is ₹46 and ₹17.35 as of 5/9/2025.
Please be aware that Beryl Drugs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account